Latest Breaking News On - Association international society - Page 4 : vimarsana.com
SEVEN RESEARCHERS HONORED FOR SCIENTIFIC ACHIEVEMENTS AND CONTRIBUTIONS TO THE DEMENTIA FIELD AT ALZHEIMER S ASSOCIATION INTERNATIONAL CONFERENCE
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Dr David Bartres-Faz new chair of the Reserve, Resilience and Protective Factors PIA of the Alzheimer s Association International Society
ub.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ub.edu Daily Mail and Mail on Sunday newspapers.
UK s Alaine E. Reschke-Hernández talks about her research exploring the impact of music on Alzheimer s patients.
LEXINGTON, Ky. (Jan. 26, 2021) Newly published research has found familiar music can elicit an extended emotional response in patients with Alzheimer’s-type dementia. The findings from this potential new approach were featured in issue three of volume 78 of the Journal of Alzheimer’s Disease.
Building on the belief that music has emotional and behavioral benefits, researchers under the leadership of University of Kentucky School of Music’s Alaine E. Reschke-Hernández, assistant professor of music therapy, set out to explore if those emotions provoked by music remain without declarative memory (conscious recollection of the music). In the article, “Hooked on a Feeling: Influence of Brief Exposure to Familiar Music on Feelings of Emotion in Individuals with Alzheimer’s Disease,” the team of researchers from UK, Missouri University of Science and Technolo
NervGen Pharma Corp.: NervGen Pharma Establishes Alzheimer s Disease Scientific Advisory Board
Vancouver, British Columbia (Newsfile Corp. - January 26, 2021) -
NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ( NervGen or the Company ), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced the formation of its Alzheimer s Disease Scientific Advisory Board ( AD-SAB ) with the appointment of four world-class scientists and clinical researchers in Alzheimer s disease: Jeffrey Cummings, MD, ScD; George Perry, PhD; Henrik Zetterberg, MD, PhD; and Bruce Lamb, PhD. The AD-SAB will work closely with NervGen as the Company plans its upcoming preclinical studies and clinical trials and in the analyses of the results from these studies.
Share or Print this page
In aggressive pursuit of its vision of a world without Alzheimer’s and all other dementia, the Association once again made its
largest-ever research investment in FY20,
granting more than $47 million to 139 new scientific investigations. Investments included awards to 119 projects funded through the
International Research Grant Program, representing proposals ranked highest by a peer-reviewed process in a highly competitive field of 406 applications submitted from 865 letters of intent. As the world’s leading nonprofit funder of Alzheimer’s and dementia research, the Association is currently investing $208 million in more than 590 active best-of-field projects in 31 countries.
The Association paused funding programs in March 2020 after hearing significant challenges from potential applicants in submitting their necessary documents for consideration as a result of the COVID-19 pandemic. The Association continues to be in touch with multi
vimarsana © 2020. All Rights Reserved.